Literature DB >> 12668049

Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum.

J F Cheer1, D A Kendall, R Mason, C A Marsden.   

Abstract

Cannabinoids are known to exert mainly excitatory effects on dopaminergic cells of the ventral tegmental area (VTA). We have utilized an in vivo multiple-single unit electrophysiological approach to assess different neuronal contributions that may ultimately lead to excitation in this area. Baseline neuron recordings, using low impedance microwires, showed a variety of waveforms with a wide range of durations (0.8-3.2 ms). In the first experiment systemic injection of the potent cannabinoid agonist HU210 (100 microg/kg, i.p.) led predominantly to an increase in firing rate (approximately 214%, compared to pre-drug) in slowly firing cells with broad action potentials, possibly driven by a majority of presumed dopaminergic neurons (n = 31). However, the firing rate of some units was either unaffected (<25%, n = 9) or even decreased (approximately 67%, n = 9) following cannabinoid injection concomitantly with excitation. Apomorphine (75 microg/kg, i.p.) injected following HU210 produced a marked inhibition of both responses (approximately 76%) in 39 out of 49 cells. The second group of animals was treated with the CB(1) receptor antagonist SR141716A (1 mg/kg, i.p.), which had no effect when injected alone but prevented all HU210-evoked changes in firing rate suggesting that cannabinoid receptors mediated the observed responses (n = 39). Taken together, the present results suggest that the observed actions of cannabinoids may involve complex neurotransmitter interactions leading to differential effects on dopamine release. These heterogeneous neuronal responses are likely to underly the behavioural discrepancies reported in animal models of cannabinoid reinforcement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668049     DOI: 10.1016/s0028-3908(03)00029-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  23 in total

1.  Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.

Authors:  Gabriel C Loewinger; Michael V Beckert; Hugo A Tejeda; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-01-25       Impact factor: 5.250

Review 2.  Monitoring rapid chemical communication in the brain.

Authors:  Donita L Robinson; Andre Hermans; Andrew T Seipel; R Mark Wightman
Journal:  Chem Rev       Date:  2008-06-25       Impact factor: 60.622

Review 3.  The endocannabinoid system in brain reward processes.

Authors:  M Solinas; S R Goldberg; D Piomelli
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

4.  Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area.

Authors:  Arthur C Riegel; Carl R Lupica
Journal:  J Neurosci       Date:  2004-12-08       Impact factor: 6.167

5.  Using dopamine research to generate rational cannabinoid drug policy.

Authors:  G C Loewinger; E B Oleson; J F Cheer
Journal:  Drug Test Anal       Date:  2012-09-19       Impact factor: 3.345

6.  Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.

Authors:  Tasha Ahmad; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-07-01       Impact factor: 4.530

7.  Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.

Authors:  David R Schulze; F Ivy Carroll; Lance R McMahon
Journal:  Psychopharmacology (Berl)       Date:  2012-02-29       Impact factor: 4.530

Review 8.  Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

9.  Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.

Authors:  David Moranta; Susana Esteban; Jesús A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-16       Impact factor: 3.000

10.  Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats.

Authors:  Nico Wegener; Sybille Kuhnert; Annika Thüns; Rasmus Roese; Michael Koch
Journal:  Psychopharmacology (Berl)       Date:  2008-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.